Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2021 Mar;35(2):698-699.
doi: 10.1111/jvim.16035. Epub 2021 Jan 27.

Letter to the editor regarding "Efficacy of adding ramipril (VAsotop) to the combination of furosemide (Lasix) and pimobendan (VEtmedin) in dogs with mitral valve degeneration: The VALVE trial"

Clarke Atkins  1 , Bruce Keene  1 , Teresa C DeFrancesco  1 , Sandra Tou  1 , Valérie Chetboul  2 , Étienne Côté  3 , Stephen Ettinger  4 , Philip R Fox  5 , Robert L Hamlin  6 , Jonathan P Mochel  7 , Jean-Louis Pouchelon  2 , Rebecca L Stepien  8
Affiliations
Comment

Letter to the editor regarding "Efficacy of adding ramipril (VAsotop) to the combination of furosemide (Lasix) and pimobendan (VEtmedin) in dogs with mitral valve degeneration: The VALVE trial"

Clarke Atkins et al. J Vet Intern Med. 2021 Mar.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Programmatic or institutional grant support, consultant/speaker for pharmaceutical companies marketing veterinary cardiovascular drugs are as follows: Clarke Atkins: Boehringer‐Ingelheim, CEVA Sant Animalé, Vetoquinol, Virbac; Bruce Keene: Boehringer‐Ingelheim, CEVA Santa Animalé; Teresa C. DeFrancesco: Boehringer‐Ingelheim, CEVA Santé Animale; Sandra Tou: Boehringer‐Ingelheim, CEVA Santé Animale; Valérie Chetboul: Boehringer‐Ingelheim, CEVA Santé Animale, Vetoquinol; Étienne Côté, Boehringer‐Ingelheim, CEVA Santé Animale; Stephen Ettinger: Purina‐Nestle; Philip R. Fox: Boehringer‐Ingelheim; Robert L. Hamlin: none; Jonathan P. Mochel: Boehringer‐Ingelheim, Ceva Santé Animale, Ethos, LEAH Labs, 3D Health Solutions; Jean‐Louis Pouchelon: Boehringer‐Ingelheim, CEVA Santé Animale, Vetoquinol; Rebecca L. Stepien: Boehringer‐Ingelheim, CEVA Santé Animale.

Comment in

Comment on

References

    1. Wess G, Kresken J‐G, Wendt R, et al. Efficacy of adding ramipril (VAsotop) to the combination of furosemide (Lasix) and pimobendan (VEtmedin) in dogs with mitral valve degeneration: The VALVE trial. J Vet Intern Med. 2020;174:1‐10. - PMC - PubMed
    1. Borgarelli M, Ferasin L, Lamb K, et al. DELay of appearance of sYmptoms of canine degenerative mitral valve disease treated with spironolactone and benazepril: the DELAY study. J Vet Cardiol. 2020;27:34‐53. - PubMed
    1. Bernay F, Bland JM, Haggstrom J, et al. Efficacy of spironolactone on survival in dogs with naturally occurring mitral regurgitation caused by myxomatous mitral valve disease. J Vet Intern Med. 2010;24:331‐341. - PubMed
    1. Ward J, Mochel J. Rational dose selection for ACE inhibitors in canine heart disease, 2020 ACVIM Forum on Demand Proceedings; 2020 June 11‐December 31; USA. Greenwood Village, Colorado; ACVIM; 2020.
    1. Coffman M, Guillot E, Garrelli‐Paar, C, Blondel T , et al. Clinical efficacy of a benazepril and spironolactone combination in dogs with congestive heart failure due to myxomatous mitral valve disease: The BESST Trial. J Vet Intern Med. Forthcoming 2021. - PMC - PubMed

LinkOut - more resources